BIPRU Sch 2 Notification and reporting requirements
11 The aim of the guidance in the following table is to give the reader a quick overall view of the relevant notification requirements. |
2 It is not a complete statement of those requirements and should not be relied on as if it were. |
3 Table |
Handbook reference |
Matter to be notified |
Contents of notification |
Trigger event |
Time allowed |
Adoption of or significant change to a trading book policy statement |
Copy of the trading book policy statement |
Adoption of or significant change to a trading book policy statement |
Immediately |
|
BIPRU 3.2.35 R (5) 3 |
Fact of exposure or firm ceasing to meet the conditions in BIPRU 3.2.25 R3 |
(5): Fact of exposure or firm ceasing to meet the conditions in 3BIPRU 3.2.25 R3 3 |
(5): Ceasing to meet conditions 3 |
(5): First report date after the obligation to notify becomes due5 3 |
Total sum of a firm's weighted net long and net short securitisation and resecuritisation positions, broken down by types of underlying assets |
Total sum of a firm's weighted net long and net short securitisation and resecuritisation positions, broken down by types of underlying assets |
Periodically as set out in SUP 16.12 |
In accordance with SUP 16.12 |
|
Intention to rely on approach in BIPRU 7.4.22 R (1)(b) |
Fact of intention and details on which commodities the firm intends to treat as same commodity-class and justification |
Intention to rely |
At least 20 business days prior to the date the firm starts relying on BIPRU 7.4.23 R |
|
Intention to use an exclusion under BIPRU 7.5.4 R (1) |
Fact of intention and the terms on which the relevant item will be excluded from the firm's foreign currency PRR calculation |
Intention to use |
Before use of the exclusion5 |
|
Material shortfall in the amount of capital required under the all price risk measure identified as a result of performing the stress tests under BIPRU 7.10.55Z R |
Information about the stress tests and the material shortfall in capital |
Existence of a material shortfall in capital |
No later than two business days after the business day on which the material shortfall occurred |
|
Occurrence of backtesting exception |
Fact of backtesting exception |
Orally within 2 business days, and written account of all backtesting exceptions that Month, within 5 business days after the Month |
||
Operation of the VaR model, systems and controls relating to it and changes to the VaR model and those systems and controls |
Documentation specified in the VaR model waiver/VaR model permission |
FSA specified requirements |
No later than number of business days after the end of each quarter specified in the VaR model permission |
|
Details of significant planned changes to the VaR model |
Information about the nature of the change and an estimate of the impact on VaR numbers and theincremental risk charge5 5 |
Intention to change |
Prior to any changes being implemented |
|
Serious risk that could undermine the financial stability of the CAD Article 22 group |
Fact of serious risk to group financial stability |
Events/ activities leading to serious risk to group financial stability |
As soon as the firm becomes aware of that risk |
|
BIPRU 8.4.18 R (3) |
Consolidated capital resources and consolidated capital resources requirement of the CAD Article 22 group as set out in the investment firm consolidation waiver |
Amount of CAD Article 22 group consolidated capital resources and consolidated capital resources requirement |
Periodically as set out in the investment firm consolidation waiver |
Not specified |
BIPRU 8.4.18 R (4) |
Large exposures risks of the CAD Article 22 group including undertakings not located in a member State |
Large exposures risks of the CAD Article 22 group including undertakings not located in a member State |
Periodically as set out in the investment firm consolidation waiver |
Not specified |
Intention to exclude an undertaking from consolidation |
Fact of intention and details of undertaking to be excluded |
Intention to exclude |
||
Intention of a group undertaking to issue a capital instrument for inclusion in capital resources or consolidated capital resources |
Fact of intention and details of intended amount, issue date, type of investor, stage of capital, features of instrument and confirmation of compliance with rules |
Intention to issue |
As soon as proposed issue becomes known to firm |
|
Proposed changes to details of the issue of a capital instrument notified under BIPRU 8.6.1B R |
Proposed change and all information required under BIPRU 8.6.1B R (1) to BIPRU 8.6.1B R (4) |
Intention to change any details of the issue previously notified to the FSA |
As soon as the changes are proposed |
|
Proposed establishment of a debt securities program by a group undertaking |
All information required under BIPRU 8.6.1B R (1) to BIPRU 8.6.1B R (4) |
Intention to establish |
As soon as proposed establishment becomes known to firm |
|
Issue of capital instruments by a group undertaking under BIPRU 8.6.1E R |
All information required under BIPRU 8.6.1B R (1) to BIPRU 8.6.1B R (3) and confirmation no changes have been made to the terms of the instrument from a previous similar issue |
Intention to issue |
No later than the date of issue |
|
(1) The choice of consolidation technique in BIPRU 8.7.13 R it applies for which consolidated requirement component: and (2) to which members of the relevant group it is applying the different methods in BIPRU 8.7.13 R |
(1) The choice of consolidation technique in BIPRU 8.7.13 R to be applied for each consolidated requirement component (2) the members of the relevant group to which it is applying the different methods in BIPRU 8.7.13 R |
See SUP 16 |
See SUP 16 |
|
Provision of implicit support to a securitisation |
(1) Provision of non-contractual support, and (2) The regulatory capital impact of providing implicit support |
Provision of implicit support |
Not specified |
|
Exposure being treated as exempt under BIPRU 10.8A (Core UK group) 3 ceases to meet the conditions for application of the treatment 333 |
Fact or expectation of any exposure3 to which it has applied the treatment ceases to meet the conditions for application of the treatment 33 |
Awareness of situation |
Immediately3 3 |
|
Intention to use BIPRU 10.9A.8 R (1) to concentrate an exposure to a particular member of the non-core large exposures group that exceeds 25% of the capital resources of the firm's core UK group |
Fact of intention and the information in BIPRU 10.9A.8 R (3) |
Intention to use BIPRU 10.9A.8 R (1) |
Not specified |
|
Exposure being treated as exempt under BIPRU 10.9A (Intra-group exposures: exposures outside the core UK group) ceases to meet the conditions for application of the treatment |
Fact or expectation of any exposure to which it has applied the treatment ceases to meet the conditions for application of the treatment |
Awareness of situation |
Immediately |
|
Artificial transfer, transaction or arrangement. |
Fact of entry into a transfer, transaction or arrangement of the type mentioned in BIPRU 10.12.5 R |
Entry into an artificial transfer, transaction or arrangement |
Not specified |
|
Results of the BIPRU 12.4 stress tests |
The results referred to in column (2) |
The carrying out of the BIPRU 12.4 stress tests |
To be reported in a timely manner |
|
A simplified ILAS BIPRU firm's policy statement prepared in accordance with BIPRU 12.6.13 R |
The policy statement referred to in column (2) |
The firm's decision to apply for a simplified ILAS waiver |
Prior to the firm's application for a simplified ILAS waiver |
|
The occurrence of any of the events identified in BIPRU 12.9.14 R |
Fact of occurrence and adequately reasoned explanation for the deviation |
The occurrence of any of the events identified in BIPRU 12.9.14 R |
As soon as the firm becomes aware of the event in question |
|
A firm's liquidity remediation plan |
The matters identified in BIPRU 12.9.18 R |
The occurrence of any of the events identified in BIPRU 12.9.14 R |
Within two days of the notification made under BIPRU 12.9.13 R |
|
Counterparty risk exposure of non-standard type |
Fact of exposure, counterparty involved, nature of the exposure and capital treatment adopted |
Entry into non-standard exposure |
Immediately |
|
Cessation to comply with requirements set out in BIPRU 13.6 for CCR internal model method permission |
Plan for timely return to compliance or demonstration that the effect of non-compliance is immaterial |
Ceasing to comply with requirements |
Immediately |